Operating Lease, Right-of-Use Asset of BioCorRx Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioCorRx Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • BioCorRx Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $169,443, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BioCorRx Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $169,443 -$39,266 -19% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $179,555 -$38,491 -18% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $189,468 +$118,810 +168% 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q4 2024 $199,184 +$101,906 +105% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $208,709 +$31,255 +18% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $218,046 +$8,899 +4.3% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $70,658 -$169,444 -71% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $97,278 -$173,128 -64% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $177,454 -$122,619 -41% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $209,147 -$119,843 -36% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $240,102 -$117,144 -33% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $270,406 -$114,515 -30% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $300,073 -$111,957 -27% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $328,990 -$109,449 -25% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $357,246 -$106,999 -23% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $384,921 -$104,615 -21% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $412,030 -$102,294 -20% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $438,439 +$22,304 +5.4% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $464,245 +$28,620 +6.6% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $489,536 +$30,829 +6.7% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $514,324 +$257,780 +100% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $416,135 +$149,488 +56% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $435,625 +$422,762 +3287% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $458,707 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $256,544 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $266,647 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $12,863 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.